THE EFFECT OF LEUPROLIDE ACETATE ON STEROIDOGENESIS BY GRANULOSA AND THECA CELLS-INVITRO

被引:12
作者
FREDERICK, JL [1 ]
HICKEY, MJ [1 ]
FRANCIS, MM [1 ]
SAUER, MV [1 ]
PAULSON, RJ [1 ]
机构
[1] UNIV SO CALIF,SCH MED,DEPT OBSTET & GYNECOL,DIV REPROD ENDOCRINOL,LOS ANGELES,CA 90024
来源
JOURNAL OF IN VITRO FERTILIZATION AND EMBRYO TRANSFER | 1991年 / 8卷 / 04期
关键词
LEUPROLIDE ACETATE; GRANULOSA; THECA; PORCINE;
D O I
10.1007/BF01130811
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Enhancement of follicular response to controlled ovarian hyperstimulation for human in vitro fertilization (IVF) has been suggested following pretreatment with leuprolide acetate (LA). However, additional human menopausal gonadotropin (hMG) is required to achieve follicle maturity in the presence of LA. We studied the effect of LA on steroidogenesis of granulosa and theca cells in vitro. Human granulosa cells obtained from IVF follicular fluid aspirations were cultured for 14 days in the presence and absence of human chorionic gonadotropin (hCG). hCG significantly enhanced progesterone (P) and estradiol (E2) production by the cells, however, the addition of LA in concentrations of 10, 100, and 1000 ng/ml had no effect. Porcine granulosa cells were cultured for 48 hr in the presence and absence of follicle stimulating hormone (FSH) with the addition of LA at the same doses. LA did not affect the FSH-induced increase in P production. Porcine theca cells were cultured for 48 hr in the presence and absence of hCG. The addition of LA did not affect androstenedione (A) production by these cells. We conclude that in this dynamic model in vitro, LA does not inhibit or stimulate P or E2 production by granulosa or A production by theca cells.
引用
收藏
页码:230 / 234
页数:5
相关论文
共 26 条
[1]  
Khodr G.S., Siler-Khodr T.M., Placental luteinizing hormone-releasing factor and its syntheses, Science, 207, (1980)
[2]  
Miller W.R., Scott W.N., Morris R., Fraser H.M., Sharpe R.M., Growth of human breast cancer cells inhibited by luteinizing hormone-releasing agonist, Nature, 313, (1985)
[3]  
Peiper D.R., Richards J.S., Marshal J.C., Ovarian gonadotropin-releasing hormone (GnRH) receptors: Characterization, distribution, and induction by GnRH, Endocrinology, 108, (1981)
[4]  
Ranta T., Knecht M., Kody M., Catt K.J., GnRH receptors in cultured rat granulosa cells: Medication of the inhibitory and stimulatory actions of GnRH, Mol Cell Endocrinol, 27, (1982)
[5]  
Jones P.B.C., Conn M.P., Marian J., Hseuh A.J.W., Binding of gonadotropin releasing hormone agonist to rat ovarian granulosa cells, Life Sci, 27, (1980)
[6]  
Bramley T.A., Mensies G.S., Baird D.T., Specific binding of gonadotropin releasing hormone and an agonist to human corpus luteum homogenates: Characterization, properties, and luteal phase levels, J Clin Endocrinol Metab, 61, (1985)
[7]  
Nevea S., Hedon N.B., Bringer J., Ovarian stimulation by a combination of a gonadotropin-releasing hormone agonist and gonadotropins for in vitro fertilization, Fertil Steril, 47, (1987)
[8]  
Meldrum D.R., Wisot A., Hamilton F., Gutlay A.L., Kempton W., Huynh D., Routine pituitary suppression with leuprolide before ovarian stimulation for oocyte retrieval, Fertil Steril, 51, (1989)
[9]  
Fleming R., Coutts J.R.T., Induction of multiple follicular growth in normally menstruating women with exogenous gonadotropin suppression, Fertil Steril, 42, (1986)
[10]  
Awadells S.G., Friedman C.I., Chin N.W., Et al., Follicular stimulation for in vitro fertilization using pituitary suppression and human menopausal gonadotropins, Fertil Steril, 48, (1987)